Literature DB >> 26123543

Role of epithelial-mesenchymal transition markers in triple-negative breast cancer.

Sai Yin Cheung1, Yvonne Jia Yu Boey, Valerie Cui Yun Koh, Aye Aye Thike, Jeffrey Chun Tatt Lim, Jabed Iqbal, Puay Hoon Tan.   

Abstract

Triple-negative breast cancers (TNBCs) are a heterogeneous group of breast tumours that are often associated with adverse pathological characteristics, poorer clinical outcomes and lack of targeted therapeutic options. Epithelial-mesenchymal transition, which plays a crucial role in tumour development and progression, is characterised by a transition from epithelial to mesenchymal phenotype and loss of proteins involved in maintaining cell junctions. We aimed to correlate protein expression of E-cadherin, Snail2 and transforming growth factor beta (TGF-β) with clinicopathological parameters and survivals of a series of patients with TNBC. The study cohort comprised 767 TNBCs diagnosed at the Department of Pathology, Singapore General Hospital from 1994 to 2012. Immunohistochemistry was performed on sections cut from tissue microarrays using the polymeric method. Staining intensity and percentage of positive tumour cells were evaluated and correlated with clinicopathological findings and clinical outcomes. Loss of E-cadherin expression, Snail2 positivity, cytoplasmic and nuclear expression of TGF-β were observed in 265 (35.2 %), 241 (32.0 %), 272 (36.2 %) and 262 (34.8 %) tumours, respectively. Histological grade significantly correlated with Snail2 positivity (P < 0.001) and loss of membranous E-cadherin expression (P = 0.003). Nuclear expression of TGF-β was inversely correlated with histological grade (P = 0.010). Median follow-up was 73 months, with a maximum of 236 months. Despite a graphical curve for earlier recurrence in patients with tumours harbouring a combinational phenotype of loss of membranous E-cadherin and positive Snail2 expression, there was no statistical significance. Similarly for women with tumours expressing cytoplasmic TGF-β, graphical representation showed poorer metastasis-free survival but without statistical significance. Loss of membranous E-cadherin and positive Snail2 expression are significantly associated with high-grade TNBCs. More work is needed to improve understanding of the role of TGF-β in TNBC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26123543     DOI: 10.1007/s10549-015-3485-1

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  7 in total

Review 1.  Update on the Treatment of Early-Stage Triple-Negative Breast Cancer.

Authors:  Priyanka Sharma
Journal:  Curr Treat Options Oncol       Date:  2018-04-14

2.  MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer.

Authors:  Mitchell E Menezes; Xue-Ning Shen; Swadesh K Das; Luni Emdad; Devanand Sarkar; Paul B Fisher
Journal:  Oncotarget       Date:  2016-12-06

Review 3.  Molecular Mechanisms and Emerging Therapeutic Targets of Triple-Negative Breast Cancer Metastasis.

Authors:  Christiana Neophytou; Panagiotis Boutsikos; Panagiotis Papageorgis
Journal:  Front Oncol       Date:  2018-02-22       Impact factor: 6.244

4.  NOTCH1 activation compensates BRCA1 deficiency and promotes triple-negative breast cancer formation.

Authors:  Kai Miao; Josh Haipeng Lei; Monica Vishnu Valecha; Aiping Zhang; Jun Xu; Lijian Wang; Xueying Lyu; Si Chen; Zhengqiang Miao; Xin Zhang; Sek Man Su; Fangyuan Shao; Barani Kumar Rajendran; Jiaolin Bao; Jianming Zeng; Heng Sun; Ping Chen; Kaeling Tan; Qiang Chen; Koon Ho Wong; Xiaoling Xu; Chu-Xia Deng
Journal:  Nat Commun       Date:  2020-06-26       Impact factor: 14.919

5.  Suppression of Spry1 inhibits triple-negative breast cancer malignancy by decreasing EGF/EGFR mediated mesenchymal phenotype.

Authors:  Qing He; Hongyu Jing; Lucy Liaw; Lindsey Gower; Calvin Vary; Shucheng Hua; Xuehui Yang
Journal:  Sci Rep       Date:  2016-03-15       Impact factor: 4.379

6.  Role of tumor microenvironment in triple-negative breast cancer and its prognostic significance.

Authors:  Tianjian Yu; Genhong Di
Journal:  Chin J Cancer Res       Date:  2017-06       Impact factor: 5.087

7.  CSF-1/CSF-1R axis is associated with epithelial/mesenchymal hybrid phenotype in epithelial-like inflammatory breast cancer.

Authors:  Kazuharu Kai; Takayuki Iwamoto; Dongwei Zhang; Li Shen; Yuko Takahashi; Arvind Rao; Alastair Thompson; Subrata Sen; Naoto T Ueno
Journal:  Sci Rep       Date:  2018-06-21       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.